CLINICAL_TRIALS
trial_result
· 2017-12-28
Clinical Trial Update: Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke Patients [Phase 4]
Summary
Phase 4 clinical trial update examining clopidogrel response by CYP2C19 genotype in ischemic stroke patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zealand University Hospital | Conditions: Ischemic Stroke | Phase 4 | Status: COMPLETED